[144] CryoPort, Inc. SEC Filing

Rhea-AI Filing Summary

CryoPort, Inc. (CYRX) filed a Form 144 disclosing a proposed sale of 40,728 common shares—valued at $273,284.88—through Morgan Stanley Smith Barney on or about 22 Jul 2025. The shares were obtained the same day via a cash exercise of stock options.

The insider has already completed five open-market sales during the past three months, disposing of 29,655 shares for total proceeds of $167,467.67. Including the new notice, cumulative planned and completed sales reach 70,383 shares. CryoPort reports 50,137,218 shares outstanding, so the new sale equals roughly 0.08 % of shares outstanding.

Form 144 serves only as advance notice; the transaction may or may not occur depending on market conditions and the filer’s 10b5-1 plan. The filing contains no operating, earnings, or guidance information.

Positive

• Sale comprises only ~0.08 % of total shares outstanding, indicating negligible dilution or ownership shift.

Negative

• Continued insider selling (70 k shares planned/ sold in three months) may weigh on investor sentiment despite small relative size.

Insights

Financial Analyst

TL;DR – Minor insider sale; immaterial to float, modest negative sentiment.

The filing signals an additional 40.7 k-share sale by an executive who has already sold 29.7 k shares this quarter. While insider selling can raise eyebrows, the proposed sale equals just 0.08 % of CryoPort’s 50.1 mm shares outstanding and under 1 day of average trading volume for many small-cap names. No operational data accompany the notice, so the event is not financially material; however, persistent sales may pressure sentiment if the trend continues.

Corporate Governance Expert

TL;DR – Routine Rule 144 filing tied to option exercise; low governance concern.

The shares were acquired and sold under a same-day option exercise, suggesting liquidity rather than strategic exit. The filer attests to no undisclosed adverse information and references a 10b5-1 plan, aligning with best-practice trading safeguards. Absent larger volumes or pattern escalation, the filing appears routine and not impactful to governance risk assessments.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	40728	273284.88	50137218	07/22/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/22/2025	Exercise of Stock Options	Issuer			40728	07/22/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for RAMKUMAR MANDALAM 112 Westwood Place, Suite 350 Brentwood TN 37027	Common	06/24/2025	13321	93446.82
RAMKUMAR MANDALAM 112 Westwood Place, Suite 350 Brentwood TN 37027	Common	06/13/2025	624	4246.13
RAMKUMAR MANDALAM 112 Westwood Place, Suite 350 Brentwood TN 37027	Common	06/12/2025	1895	13286.41
RAMKUMAR MANDALAM 112 Westwood Place, Suite 350 Brentwood TN 37027	Common	06/11/2025	8193	57815.54
RAMKUMAR MANDALAM 112 Westwood Place, Suite 350 Brentwood TN 37027	Common	06/09/2025	5622	39672.77

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

Why did the CYRX insider file Form 144?

To notify the SEC of an intent to sell 40,728 common shares under Rule 144 on 22 Jul 2025.

How many CryoPort shares are being sold?

The notice covers 40,728 shares, valued at $273,284.88 based on prevailing market prices.

What percentage of CYRX’s shares does the proposed sale represent?

Approximately 0.08 % of the company’s 50,137,218 shares outstanding.

Has the insider sold CYRX shares recently?

Yes. Over the past three months the insider sold 29,655 shares for $167,467.67 in gross proceeds.

Does the filing include any financial results or guidance?

No. Form 144 only discloses the planned share sale and contains no operating or earnings data.